Kirn David
Kirn David, SR, reported a transaction classified as exercise at 4D Molecular Therapeutics, Inc. involving 50000.000000 shares for an estimated $207000.00. Reported holdings after the transaction were 894895.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Aug 19, 2026
- Filing date
- Aug 21, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
FDMT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-361096 Common Stock
- Transaction date
- Aug 19, 2026 Filed Aug 21, 2026, 08:06 PM · 2d delay
- Shares
- 50,000 sh $4.14 per share
- Estimated value
- $207k Computed from shares × price
- Holdings after
- 894,895 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
See Remarks
- F1
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 9, 2026.
- F2
The transaction was executed in multiple trades in prices ranging from $14.91 to $15.84, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person…
- F3
The transaction was executed in multiple trades in prices ranging from $15.97 to $16.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person…
- F4
The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), suc…
0 other transactions
0 recent txs